Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

39.14
+0.85002.22%
Pre-market: 39.690.5500+1.41%05:25 EDT
Volume:10.44M
Turnover:405.95M
Market Cap:174.76B
PE:9.78
High:39.22
Open:38.67
Low:38.56
Close:38.29
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.19
T/O Rate:0.33%
Dividend:1.80
Dividend Rate:4.61%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.37
PE(LYR):10.81

Loading ...

Earning Preview: Novo-Nordisk A/S this quarter’s revenue is expected to decrease by 5.20%, and institutional views are bearish

Earnings Agent
·
Oct 28

Moderately bullish activity in Novo Nordisk with shares up 1.27%

TIPRANKS
·
Yesterday

Eli Lilly Shares Trending On Retatrutide Win Ahead Of Earnings: What You Should Know

Benzinga Earnings
·
Yesterday

Novo Stock (NVO) Falls After Another Head-to-Head Obesity Trial Loss to Eli Lilly

TIPRANKS
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Yesterday

The U.S. Government Will no Longer Penalize American Companies for Making Six Popular Peptides

Dow Jones
·
Yesterday

Novo Nordisk Advances Mim8 Trial in Rare Haemophilia A, Expanding Its Specialty Pipeline

TIPRANKS
·
Yesterday

Novo Nordisk (0QIU) Gets a Hold from J.P. Morgan

TIPRANKS
·
Oct 28

Lilly's Retatrutide Delivers More than Double Ozempic's Weight Loss in Phase 3 Trial

Reuters
·
Oct 28

Lilly's Retatrutide Delivered Greater A1c Reduction and More than Double the Weight Loss of Ozempic's Highest Approved Dose in Head-to-Head Trial

THOMSON REUTERS
·
Oct 28

Sector Update: Healthcare

MT Newswires Live
·
Oct 28

US Judge Lets Eli Lilly Continue Weight-Loss Drug Ads, Ruling Against Novo Nordisk

THOMSON REUTERS
·
Oct 27

Novo Nordisk A/S Series B Stock Rises Monday, Underperforms Market

Dow Jones
·
Oct 27

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Oct 27

A 42% Risk Reduction—and an 18% Stock Drop

Bellwether Stocks Movement
·
Oct 24

Moderna’s Cancer Vaccine Passed Phase 3. What Spooked Investors?

Bellwether Stocks Movement
·
Oct 24

FDA approves Novo Nordisk’s Awiqli for type 2 diabetes in kids 10 and older

TIPRANKS
·
Oct 24

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Oct 24

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Oct 22